Labshake search
Citations for R&D Systems :
551 - 600 of 1565 citations for Recombinant Bovine KITLG Protein since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2023Quote: ... 40ng/mL recombinant human FGF (R&D systems, 100-18B-100), 0.5 × B27 serum free supplement (ThermoFisher Scientific ...
-
bioRxiv - Immunology 2023Quote: ... with or without 200ng/mL recombinant human BAFF (R&D Systems). After overnight culture ...
-
bioRxiv - Biochemistry 2023Quote: ... 125 μM ubiquitin (yeast recombinant from bio-techne (R&D Systems)) ...
-
bioRxiv - Developmental Biology 2023Quote: ... 10ng/mL recombinant human FGF7 (R&D Systems, Cat#251-KG), and 3µM CHIR99021 (APExBIO ...
-
bioRxiv - Microbiology 2023Quote: ... 1 µg/mL recombinant human R-spondin-1 (R&D systems), 500 nM A83-01 (R&D systems) ...
-
bioRxiv - Microbiology 2023Quote: ... 1 µg/mL recombinant human R-spondin-1 (R&D systems), 500 nM A83-01 (R&D systems) ...
-
bioRxiv - Bioengineering 2023Quote: ... Recombinant TNFα was purchased from R&D Systems (cat #: 210TA100/CF) and recombinant MCP-1 was purchased from BD Biosciences (cat # ...
-
bioRxiv - Biochemistry 2023Quote: ... and Ub-Propargyl (recombinant human) were purchased from R&D systems. DNA for Smurf1 ...
-
bioRxiv - Neuroscience 2023Quote: ... mouse recombinant carrier free MCSF 10 ng/mL (R&D Systems) and human recombinant TGF-β1 50 ng/mL (Miltenyi Biotec).
-
bioRxiv - Bioengineering 2023Quote: ... and 20 ng/mL human recombinant FGF-4 (R&D Systems). After 9 to 13 days ...
-
bioRxiv - Immunology 2024Quote: Recombinant human IL-2 (Proleukin) was purchased from R&D Systems or obtained from the National Cancer Institute’s Biological Research Branch ...
-
bioRxiv - Bioengineering 2023Quote: ... with 20 ng/mL human recombinant Oncostatin M (R&D Systems). On differentiation day 25 ...
-
bioRxiv - Neuroscience 2024Quote: ... Recombinant human legumain/asparginyl endopeptidase (# 2199-CY-010, R&D Systems) was used as a standard (18.31 to 2343.75 pg/ml) ...
-
bioRxiv - Cell Biology 2024Quote: ... and 30ng/mL recombinant mouse IFNγ (R&D Systems: 485-MI).
-
bioRxiv - Cancer Biology 2024Quote: ... and recombinant human IL-7 (5 ng/mL) (R&D Systems).
-
bioRxiv - Bioengineering 2024Quote: ... recombinant human fibroblastic growth factor basic (FGF-2, R&D Systems), dimethyl sulfoxide (anhydrous ...
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL recombinant human EGF (R&D system; 236-EG), 0.5 µM A 83-01 (R&D Systems ...
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL recombinant human EGF (R&D system; 236-EG), 0.5 µM A 83-01 (R&D Systems ...
-
bioRxiv - Cell Biology 2024Quote: ... human recombinant macrophage-colony stimulating factor (M-CSF, R&D Systems), Lysoview-633 (biotium) ...
-
bioRxiv - Cell Biology 2022Quote: ... 1% fetal bovine serum (R&D systems), 2.5% HEPES (Corning ...
-
bioRxiv - Microbiology 2020Quote: ... were incubated with activated human recombinant CatL (R&D systems, Minneapolis, MN) at 2 ng/µl or THL (Sigma-Aldrich ...
-
Tuning trophoblast invasion in a gelatin hydrogel via soluble cues from the maternal-fetal interfacebioRxiv - Bioengineering 2020Quote: ... Recombinant human transforming growth factor β1 (TGFβ1; R&D Systems, 240-B) and recombinant human epidermal growth factor (EGF ...
-
bioRxiv - Cancer Biology 2021Quote: ... or 200 ng/ml recombinant human IGF2 (292-G2, R&D Systems) for 24 hours before measuring cell viability ...
-
bioRxiv - Cancer Biology 2021Quote: ... c-Met signalling was stimulated with recombinant human HGF (R&D Systems) at a final concentration of 75 nM ...
-
bioRxiv - Cell Biology 2020Quote: ... 100 ng/ml Recombinant Human/Mouse/Rat Activin A (R&D Systems) and 3μM CHIR99021 (Stemgent) ...
-
bioRxiv - Immunology 2021Quote: ... Recombinant mouse MAdCAM-1-Fc was from R&D Systems (Minneapolis, MN).
-
bioRxiv - Cell Biology 2022Quote: ... Some cells were treated 0.01µg/ml recombinant human WNT3A (R&D Systems) as positive control ...
-
bioRxiv - Developmental Biology 2022Quote: ... Tocris)71–73 or recombinant Fgfr2iiib-Fc (100µg/30g mouse, R&D Systems) was used ...
-
bioRxiv - Immunology 2021Quote: Recombinant mouse IFN-γ was obtained from R&D Systems (485-MI) and used at 6.25 ng/mL ...
-
bioRxiv - Immunology 2019Quote: ... Recombinant Mouse Interferon Alpha-A (IFNα, R&D Systems, Inc. Minneapolis, MN) was administered either intratumorally or intramuscularly ...
-
bioRxiv - Developmental Biology 2019Quote: ... NIBR0213 (Novartis) and recombinant carrier-free human VEGF-A165 (R&D systems).
-
bioRxiv - Cell Biology 2019Quote: ... and 10ng/ml TGF-β3 (recombinant human, R&D Systems, Minneapolis, MA). On day 21 ...
-
bioRxiv - Pathology 2019Quote: ... Recombinant Human IL-34 (100ng/mL, R&D systems 5265-IL-010), CSF-1 Recombinant Human Protein (25ng/mL ...
-
bioRxiv - Immunology 2021Quote: ... All recombinant cytokines were obtained from R&D Systems (Minneapolis, MN USA).
-
bioRxiv - Cell Biology 2020Quote: ... and treated with 10 ng/ml rat recombinant EGF (R&D Systems) for 5 min ...
-
bioRxiv - Bioengineering 2020Quote: ... and S20-Z AZPs were incubated with recombinant PRSS3 (R&D Systems); S5-Z ...
-
bioRxiv - Bioengineering 2020Quote: ... Recombinant human Wnt7a (Chinese Hamster Ovary cell line-derived, R&D Systems) at a concentration of 50 ng/mL was used for the culture displayed on Supp.Fig.1.
-
bioRxiv - Cancer Biology 2021Quote: ... Recombinant human Wnt3A (5036-WN-010) was purchased from R&D Systems. For knockdown experiments ...
-
bioRxiv - Cancer Biology 2020Quote: ... Before recombinant MSP treatment (100ng/mL; R&D systems #6244-MS-025), cells were serum starved in 0.2% FSC overnight ...
-
bioRxiv - Cell Biology 2021Quote: ... and human recombinant TNFα was from R&D Systems (Minneapolis, MN, USA). Purified human integrin α5β1 and anti-α5 (MAB1956Z ...
-
bioRxiv - Genomics 2019Quote: ... after treatment with human recombinant IFNg (5 ng/mL, R&D Systems) overnight and stimulation with PMA (30 ng/mL ...
-
bioRxiv - Molecular Biology 2020Quote: ... and Recombinant Human IL-10 (1064-IL-010, R&D Systems, USA). In all cases ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 100 ng/ml recombinant mouse (rm) SCF (R&D Systems) and 50 ng/ml rmTPO (R&D Systems) ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were treated with 100 ng/ml recombinant WNT3A (R&D Systems).
-
bioRxiv - Biophysics 2020Quote: ... and 100ng/mL of recombinant interferon-γ (IFN-γ, R&D Systems) in RPMI-1640 media for 25min ...
-
bioRxiv - Biophysics 2020Quote: ... 10ng/mL recombinant tumor necrosis factor-α (TNF-α, R&D Systems), and 100ng/mL of recombinant interferon-γ (IFN-γ ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 30 ng/mL recombinant human EGF (R&D Systems, Minneapolis, MN). Cells were plated in a non-tissue culture treated 6-well plate and incubated overnight at 37°C ...
-
bioRxiv - Immunology 2022Quote: ... cell culture plates were coated with recombinant DLL4-FC (R&D systems) overnight at 4°C at 0.5 μg/mL prior to the addition of FLS and cytokines ...
-
bioRxiv - Molecular Biology 2022Quote: ... Recombinant interferon-β (IFNβ) (8324-MB) was purchased from R&D Systems. It was reconstituted it at 100 μg/mL in sterile PBS containing 0.1% BSA and injected (i.p. ...
-
bioRxiv - Bioengineering 2022Quote: ... or 1000 ng/mL of recombinant human IFN-γ (R&D Systems), TNF-α (R&D Systems) ...